Key Insights

Highlights

Success Rate

89% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

7.0%

3 terminated out of 43 trials

Success Rate

88.9%

+2.4% vs benchmark

Late-Stage Pipeline

19%

8 trials in Phase 3/4

Results Transparency

33%

8 of 24 completed with results

Key Signals

8 with results89% success

Data Visualizations

Phase Distribution

31Total
Not Applicable (18)
P 1 (2)
P 2 (3)
P 3 (3)
P 4 (5)

Trial Status

Completed24
Unknown10
Recruiting4
Terminated3
Enrolling By Invitation1
Not Yet Recruiting1

Trial Success Rate

88.9%

Benchmark: 86.5%

Based on 24 completed trials

Clinical Trials (43)

Showing 20 of 20 trials
NCT06260878Phase 4RecruitingPrimary

Short-term Intravenous Fluids for Prevention of Post-ERCP Pancreatitis

NCT05664074Phase 4CompletedPrimary

Rectal Indomethacin vs Intravenous Ketorolac

NCT07391787CompletedPrimary

Low-acid Contrast Media for Preventing Post ERCP Pancreatitis

NCT05252754Phase 3RecruitingPrimary

Rectal Indomethacin and Oral Tacrolimus Versus Combination to Prevent Post-ERCP Pancreatitis

NCT07117318Not ApplicableRecruitingPrimary

Rectal NSAIDs With/Without PD Stent for PEP Prevention

NCT05336630Not ApplicableCompletedPrimary

Study of Forceps Cannulation During ERCP

NCT07173179Phase 4CompletedPrimary

Papillary Epinephrine Injection Combined With Rectal Indomethacin

NCT05267379RecruitingPrimary

An European Multi-centre Cohort Study for Unravelling Pharmacokinetic and Genetic Factors Underlying Post-ERCP Pancreatitis

NCT06727851Enrolling By InvitationPrimary

ESGE-Quality Improvement in Endoscopy: ERCP

NCT04691674Not ApplicableCompleted

Optimal Placement Duration of Pancreatic Duct Stent

NCT05947461Not ApplicableTerminatedPrimary

Prevention of Post-ERCP Pancreatitis by Indomethacin Vs Diclofenac

NCT06367322CompletedPrimary

Statins and Post-ERCP Acute Pancreatitis (Stark Project)

NCT05800626UnknownPrimary

Prediction of PEP Based on the Appearance of the Major Duodenal Papilla

NCT04546867Not ApplicableCompletedPrimary

Establishing a Sonographic Based Algorithm to Verify Pancreatic Stent Position Placed to Prevent Post-ERCP Pancreatitis Before Endoscopic Removal

NCT05310409CompletedPrimary

PAN-PROMISE to Detect Post-ERCP Pancreatitis Symptoms

NCT05857514Not ApplicableUnknownPrimary

Randomized Controlled Trial of Rectal Indomethacin Versus Combined Pancreatic Stent Placement and Rectal Indomethacin for Preventing Post-ERCP Pancreatitis

NCT03098082Not ApplicableCompletedPrimary

Urine Trypsinogen 2 Dipstick for the Early Detection of Post-ERCP Pancreatitis

NCT02602574UnknownPrimary

ERCP-induced and Non-ERCP Induced Acute Pancreatitis: Two Distinct Clinical and Immunological Entities?

NCT04770857UnknownPrimary

Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis

NCT01855841Phase 2CompletedPrimary

Hemin to Prevent Post-ERCP (Endoscopic Retrograde Cholangiopancreatography) Acute Pancreatitis

Scroll to load more

Research Network

Activity Timeline